Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/18/19 17:23 | 9/16/19 | INNV | Health | Drug | Pharmaceutical Preparations | Armistice Capital, LLC | NY | T | P.m | 47 | 2.56 | 0 | 18 | 3 | 600 | M | |||||||||||||||
11/27/17 19:45 | 11/23/17 | INNV | Health | Drug | Pharmaceutical Preparations | Esber Henry Jemil | CA | D | P | 9 | 0.0929 | 0 | 100 | New | 100 | D | |||||||||||||||
11/27/17 19:45 | 11/22/17 | INNV | Health | Drug | Pharmaceutical Preparations | Berholtz Randy | CA | O | EVP,CORP | P | 2 | 0.0966 | 0 | 17 | New | 17 | D | ||||||||||||||
6/14/13 21:30 | 6/12/13 | INNV | Financ | AcqCo | Blank Checks | Damaj Bassam | CA | DOT | P,CEO | P | 135 | 0.3230 | 0 | 417 | 9 | 5,181 | M | ||||||||||||||
2/13/13 19:08 | 2/2/13 | INNV | Financ | AcqCo | Blank Checks | Damaj Bassam | CA | DOT | P,CEO | P.a | 119 | 0.4752 | 0 | 250 | 6 | 4,764 | D | ||||||||||||||
2/5/13 17:14 | 2/2/13 | INNV | Financ | AcqCo | Blank Checks | Damaj Bassam | CA | DOT | P,CEO | P | 119 | 0.4752 | 0 | 250 | New | 250 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |